Luoxin group (Stock code: 002793) is one of the leading pharmaceutical companies in China, which is engaged in pharmaceutical research & development, manufacturing, sales and healthcare service.
At present, Luoxin Group has five production sites that include Luoxin main workshop, Yuxin preparation branch, Hengxin crude material branch, Lekang Traditional Chinese Medicine branch and Luoxin Aurovitas BFS branch. Now Luoxin Group has more than 50 production lines, 300 product specifications covering more than 10 dosage forms that have been on the market. Now we can produce tablets, capsules, granules, dry suspension, pellets, powder injection, freeze-dried powder injection, aerosols, sprays, prefilled, small volume injection and large volume injection.
In recent years the Group is stepping forwards internationalization and develops rapidly with an annual output of 1 billion powder injection, 500 million freeze-dried powder for injection, 400 million large volume injection, 500 million small volume injection, 7 billion tablets, 2 billion capsules, 300 million packs of granules, 80 million packs of dry suspension, 300 metric tons of pellets, 100 million pieces of sprays and 30 million of aerosols and so on.
Sincerely wish to progress with you hand in hand to create a mutual resplendence.
